leadf
logo-loader
LSE:DDDD

4D pharma plc

Receive alerts
Market:
LSE
Market Cap:
£161.61 m
Price
122.82 GBX
Change
-8.00%
52 weeks high
183.00
52 weeks low
23.50

In brief

4D are pioneers in harnessing bacteria as a revolutionary new class of medicines – called live biotherapeutics.

Snapshot

Working in the emerging area of the human microbiome, the company has developed candidates in cancer, gastrointestinal and respiratory ailments, and autoimmune disease